Showing results (1-10 of 135) with videos related to
Sort By:
Pageof 14
Cell Death and Differentiation|March 26, 2003
Apoptosis in hepatitis C virus infectionH Bantel, K Schulze-OsthoffEuropean Cytokine Network|January 16, 1999
Activation of caspases by death receptorsH Bantel, T Brüning, K Schulze-OsthoffEuropean Journal of Cell Biology|April 27, 2001
Detection of elevated caspase activation and early apoptosis in liver diseasesH Bantel, P Ruck, M Gregor, et al.Cell Death & Disease|October 26, 2013
Increased plasma levels of CK-18 as potential cell death biomarker in patients with HELLP syndromeK John, S Wielgosz, K Schulze-Osthoff, et al.Zeitschrift Fur Gastroenterologie|March 14, 2014
[Cytokeratin 18 as marker for non-invasive diagnosis and prognosis of acute and chronic liver diseases]A Canbay, A Feldstein, B Kronenberger, et al.Cancer Research|May 8, 1999
Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosisH Bantel, I H Engels, W Voelter, et al.The American Journal of Gastroenterology|January 11, 2001
Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitisH Bantel, C Berg, M Vieth, et al.The Journal of Cell Biology|November 7, 2001
alpha-Toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signalingH Bantel, B Sinha, W Domschke, et al.Hepatology (Baltimore, Md.)|October 5, 2001
Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infectionH Bantel, A Lügering, C Poremba, et al.Alimentary Pharmacology & Therapeutics|August 4, 2016
Serum cell death biomarker mirrors liver cancer regression after transarterial chemoembolisationB Bock, D Hasdemir, F Wandrer, et al.Pageof 14